House Bill 5568
115th Congress(2017-2018)
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
Introduced
Introduced in House on Apr 18, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5568
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)
April 18, 2018
04/18/2018
Referred to the House Committee on Energy and Commerce.
04/18/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:39:49 PM